Orchard Rx Ltd. ORTX 深 沪
等待开盘 12-03 09:30:00 美东时间
16.70
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 16.70
- 总市值 3.80亿
- 52周最高 16.72
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.24
- 委 比 0.00%
- 总股本 2272.72万
- 历史最高 216.40
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.601
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD
Zevra Therapeutics announced the appointment of Alicia Secor to its Board of Directors and the retirement of Wendy Dixon, PhD. Ms. Secor brings over 30 years of experience in the life sciences industry, including leadership roles at Atalanta Therapeutics, Juniper Pharmaceuticals, and Genzyme. The company emphasizes her expertise in rare disease and her ability to support its strategic goals. Zevra is focused on developing therapies for rare disea...
12-02 12:30
XORTX Therapeutics Announces US$1.1 Million Direct Offering
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has provided an update. On October 21, 2...
10-21 20:27
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Replimune Group (NASDAQ:REPL) stock increased by 95.3% to $8.79 during...
10-20 20:08
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Shares of Delcath Systems Inc (NASDAQ:DCTH) rose sharply in pre-market trading ...
10-20 17:10
XORTX Expands Kidney Disease Pipeline With $3M Acquisition Of Vectus' VB4-P5 Therapeutic Program
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
10-17 19:10
Vectus Biosystems Sells Renal Compound to XORTX Therapeutics
The latest update is out from Vectus Biosystems Limited ( ($AU:VBS) ). Vectus B...
10-17 16:18
XORTX Therapeutics Initiates IND Preparation For XRx-026, Focused On Treatment Of Gout
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
09-03 19:09
XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has shared an announcement. XORTX Therap...
08-09 08:38
XORTX Therapeutics Completes US$925,000 Private Placement to Fund Gout Programs
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has shared an announcement. XORTX Therap...
07-23 08:32
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) rose sharply in today's pre-m...
07-07 18:26
